UNSPSC 51131524: Iron Dextran

Iron Dextran is an injectable low-molecular-weight ferric hydroxide complex indicated for patients with iron deficiency anemia where oral iron therapy is ineffective or poorly tolerated.

UNSPSC 51131524 Iron Dextran is a Commodity code with minimal relevant recent activity in state and local procurement. The code nominally covers iron dextran, a parenteral iron supplement used in clinical and veterinary settings, yet the recent opportunities dataset contains no solicitations for iron dextran itself. Instead, the tagged opportunities span unrelated categories—naloxone and drug deactivation systems (Seminole County, Florida), BLS/ALS pharmaceuticals and vending machines (City of Tucson Fire Department), forensic drug reference standards (Pinellas County, Florida), generic pharmaceuticals through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance), and vendor outreach events with no procurement scope. The source shows no issuing bodies specifically procuring iron dextran, no representative RFPs or ITBs for the product, and no geographic concentration of activity tied to the code's nominal commodity. The divergence between the code name and the actual content of recent notices suggests either miscoding of opportunities in the state and local system or extremely limited current demand for iron dextran under this UNSPSC designation.

The code shows no recent state or local contract opportunities directly soliciting iron dextran. This appears to be a specialized pharmaceutical input with infrequent state and local procurement activity, or the code may not be in active use by the jurisdictions currently posting opportunities. Business development professionals should verify whether their iron dextran offering aligns with clinical pharmacy, emergency medical services, or correctional health contracting cycles in target jurisdictions before committing resources to pursue work under this code.